- Biomarkers for Circadian Timing
- Breath Biomarkers for Sleep Loss and Circadian Timing
- Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
- Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
- Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
- Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
- Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
- Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
- Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Clinical Trials
- A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)
- A Dose-Finding Study of MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)
- Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
- A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)
- A Dose-Finding Study of MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)
- Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
- CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV Melanoma
- Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
- Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
- Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
- Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma
- STA-9090(Ganetespib) in Metastatic Ocular Melanoma
- Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
- Study of Metastatic Ocular Melanoma
- THE IPI – Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
- The Role of Inflammation in Ocular Tumours
- Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy
- Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders
- Natural History Study of Oculopharyngeal Muscular Dystrophy
- Pathology Analysis of OPMD Patient Myotomies
- Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
- Screening in Oculopharyngeal Muscular Dystrophy
- Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
- A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
- A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
- A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
- A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
- A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
- A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
- Abemaciclib in Patients With Oligodendroglioma
- Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
- All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
- Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
- Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
- Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
- Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
- Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
- Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma
- Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
- Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
- Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
- Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
- Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
- Everolimus in Treating Patients With Recurrent Low-Grade Glioma
- Everolimus With and Without Temozolomide in Adult Low Grade Glioma
- FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
- First in Patient Study for PF-06840003 in Malignant Gliomas
- Genetic Analysis of Brain Tumors
- Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
- HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
- Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
- Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
- Investigational Imaging Technique During Brain Surgery
- Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
- Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
- Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
- Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
- Neural Basis of Language Processing
- NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma
- PARP Inhibition for Gliomas (PI-4G or π4g)
- Pediatric Long-Term Follow-up and Rollover Study
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
- Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
- PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
- Prolonged Daily Temozolomide for Low-Grade Glioma
- Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
- Proteomic Characterization of Aggressive Oligodendrogliomas
- Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes
- Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
- Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
- RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
- Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
- Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma
- Social Determinants of Health in Glioblastoma Population
- Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma
- Sunitinib in Treating Patients With Recurrent Malignant Gliomas
- Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
- Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
- Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
- Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
- The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
- Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
- Treatment Strategy for Low-grade Gliomas
- Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
- A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
- Adapting a Web-Based Professional Development for Mexican School Mental Health Providers Delivering Evidence-Based Intervention for ADHD and ODD
- Addressing Depression and Positive Parenting Techniques (ADAPT)
- An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).
- Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents
- Behavioral Sleep Intervention in Children With Disruptive Behaviors
- Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits
- Big Feelings: A Study on Children’s Emotions in Therapy
- Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
- Collaborative Care for Children’s Mental Health Problems
- Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
- Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany
- Comparison of Two Psychosocial Therapies for Treating Children With Oppositional-Defiant Disorder
- Correlating Real and Virtual World Behavioral Fluctuations in Adolescence
- Enhanced Support for Behavioral Barriers to Learning: An Evaluation of the SCHOOL STARS Program
- Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
- Evaluating the Feasibility of Internet-delivered PCIT
- Evaluation of Regulation Focused Psychotherapy for Children
- Guided Self-Help for Parents of Children With Externalizing Problem Behavior
- Home Based Treatment for Drug Use in Early Adolescents
- Integrated Smart Speaker Promoting Positive Parenting Among Caregivers of Youth With Challenging Behaviors
- Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
- Investigation of Psychophysiological Correlation of Aggression and Response to Aversive Stimuli
- Investigation of Psychophysiological Response to Aversive Stimuli Over Time With Omega-3
- Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges
- Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
- Metabolic Effects of Antipsychotics in Children
- Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
- Mindful Parenting and Parent Training Program Study
- Mindfulness-based Program for Children With Disruptive Behavior Disorder
- Monitoring of Sleep and Behavior of Children 3-7 Years Old Receiving Parent-Child Interaction Therapy With the Help of Artificial Intelligence
- Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth
- On-line Treatment for Conduct Problems
- Parent Training and Emotion Coaching for Children With Limited Prosocial Emotions
- Phone-Delivered Psychological Intervention (t-CETA) for Mental Health Problems in 8-17 Year-Old Syrian Refugee Children
- Preschool First Step to Success: An Efficacy Replication Study
- Prevention of Oppositional Defiant and Conduct Disorders in Preschool Children
- Randomized Controlled Trial of Comet Via the Internet or in Group Format.
- Randomized Feasibility Trial of Mind My Mind
- Remote School-Home Program to Improve Youth Attention and Behavior in Mexican Students
- Resources to Enhance the Adjustment of Children (REACH)
- Responding to Children and Adolescents With Tyrannical Behaviour
- School-Based Mental Health Services for Urban Children
- Strongest Families Ontario (Formerly the Family Help Program)
- Study of Cognition and Control in Youths
- Supplements and Social Skills Intervention Study
- Symptoms and Mechanisms of Child Psychiatric Disorders
- The Effectiveness of Parent-Child Interaction Therapy (PCIT)
- Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
- Treatment of Children With Peer Related Aggressive Behavior
- Treatment of Children With Peer Related Aggressive Behavior (ScouT)
- Treatment of Conduct Problems and Depression
- Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to
- Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders